Clinical Trial Update: Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tucatinib for metastatic breast cancer with isolated brain progression. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Tucatinib (tucatinib)

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Breast Cancer With a Isolated Brain Progression | Phase 2 | Status: ACTIVE_NOT_RECRUITING